Changes in Lipid and Hematological Indices among Saudi Patients with Chronic Hepatitis B in the Makkah Region: A Case‒Control Study
DOI:
https://doi.org/10.22317/jcms.v11i1.1710Keywords:
Hepatitis B virus, Lipid abnormalities, Hematological parameters, Low platelet count, HDL, Viral infection, Thrombocytopenia, Metabolic, Chronic liver disease, CHB, HBV.Abstract
Objectives: This study investigates hematologic and lipid abnormalities in chronic hepatitis B (CHB) patients to better understand its systemic effects and improve treatment strategies.
Methods: We compared 226 CHB patients to an equivalent number of non-HBV individuals between 2015 and 2021 in this retrospective study. Patient data were obtained from the Ministry of National Guard Health Affairs-Western Region (MNGHA-WR) database. Categorical data was analyzed using a chi-square test, while numerical variables were tested using a t-test with a significance threshold of P < 0.05. Age and gender adjustments were made to ensure the comparability of the results.
Results: The sex distribution of the CHB and non-HBV groups was comparable (P = 0.51), although non-HBV individuals were significantly older than those with CHB. CHB patients had significantly lower levels of HDL, TC, TG, WBC, RBC, PLT, Hgb, and MCHC, as well as decreased HCT and MCV, compared to non-HBV patients (P < 0.05). These differences persisted statistically significant even after adjusting for age and gender, except for TC and TG levels.
Conclusion: This study sheds light on the altered lipid and hematologic profiles of CHB patients as compared to non-HBV individuals. Our findings may help us better understand the extrahepatic consequences associated with CHB and establish an improved medical strategy for these patients.
References
Thio, C. L., Guo, N., Xie, C., Nelson, K. E., & Ehrhardt, S. (2015). Global elimination of mother-to-child transmission of hepatitis B: revisiting the current strategy. The Lancet Infectious Diseases, 15(8), 981–985.
"Hepatitis B." World Health Organization, World Health Organization, [https://www.who.int/news-room/fact-sheets/detail/hepatitis-b].
Alghamdi, M., Alghamdi, A. S., Aljedai, A., Khathlan, A. A., Masri, N. A., Qutub, A., Quaiz, M. A., Sanai, F., Subahi, G., & Sulimani, S. (2021). Revealing hepatitis B virus as a silent killer: a call-to-action for Saudi Arabia. Cureus, 13(5).
Aljumah, A. A., Babatin, M., Hashim, A., Abaalkhail, F., Bassil, N., Safwat, M., & Sanai, F. M. (2019). Hepatitis B care pathway in Saudi Arabia: current situation, gaps and actions. Saudi Journal of Gastroenterology: Official Journal of the Saudi Gastroenterology Association, 25(2), 73.
Li, D., Hamadalnil, Y., & Tu, T. (2024). Hepatitis B Viral Protein HBx: Roles in Viral Replication and Hepatocarcinogenesis. Viruses, 16(9), 1361.
Jeng, W.-J., Papatheodoridis, G. V, & Lok, A. S. F. (2023). Hepatitis B. The Lancet, 401(10381), 1039–1052. https://doi.org/https://doi.org/10.1016/S0140-6736(22)01468-4
Rao, G., Peng, X., Li, X., An, K., He, H., Fu, X., Li, S., & An, Z. (2023). Unmasking the enigma of lipid metabolism in metabolic dysfunction-associated steatotic liver disease: from mechanism to the clinic. Frontiers in Medicine, 10, 1294267.
Wang, C., Cheng, P., & Kao, J. (2020). Systematic review: chronic viral hepatitis and metabolic derangement. Alimentary Pharmacology & Therapeutics, 51(2), 216–230.
Jose-Abrego, A., Roman, S., Laguna-Meraz, S., & Panduro, A. (2023). Host and HBV interactions and their potential impact on clinical outcomes. Pathogens, 12(9), 1146.
Mao, W., & Wu, J. (2020). Haematologic indices in hepatitis B virus-related liver disease. Clinica Chimica Acta, 500, 135–142.
Osuji, A. I., Agbakoba, N. R., Ifeanyichukwu, M. O., Enweani, I., & Abdullahi, I. N. (2020). Hepatitis B Virus Infection and Biomarkers Correlates of Liver Injury among Healthy Blood Donors in Nigeria. Journal of Advances in Medicine and Medical Research, 69–78.
Rasheed, H., Khawar, M. B., Habiba, U., Aman, S., Shah, S. S., Afzal, A., Hamid, S. E., Abbasi, M. H., Sheikh, N., & Rafiq, M. (2022). Variations in Peripheral Hematological Parameters as a Diagnostic Biomarker of HBV Infection. Asian Journal of Health Sciences, 8(2), ID45–ID45.
Ramatchandirin, B., Pearah, A., & He, L. (2023). Regulation of liver glucose and lipid metabolism by transcriptional factors and coactivators. Life, 13(2), 515.
Arvind, A., Osganian, S. A., Cohen, D. E., et al. (2019). Lipid and lipoprotein metabolism in liver disease. In K. R. Feingold, B. Anawalt, M. R. Blackman, et al. (Eds.), Endotext [Internet]. MDText.com, Inc. https://www.ncbi.nlm.nih.gov/books/NBK326742/
Joo, E. J., Chang, Y., Yeom, J. S., Lee, Y. G., & Ryu, S. (2017). Hepatitis B infection is associated with an increased incidence of thrombocytopenia in healthy adults without cirrhosis. Journal of Viral Hepatitis, 24(3), 253–258. https://doi.org/10.1111/jvh.12642
Arain, S. Q., Talpur, F. N., Channa, N. A., Ali, M. S., & Afridi, H. I. (2018). Serum lipids as an indicator for the alteration of liver function in patients with hepatitis B. Lipids in Health and Disease, 17(1), 1–10. https://doi.org/10.1186/s12944-018-0683-y
Quaye, O., Amuzu, B. G., Adadey, S. M., & Tagoe, E. A. (2019). Effect of Hepatitis B Virus (HBV) Infection on Lipid Profile in Ghanaian Patients. Virology: Research and Treatment, 10. https://doi.org/10.1177/1178122X19827606
Wong, V. W. S., Wong, G. L. H., Chu, W. C. W., Chim, A. M. L., Ong, A., Yeung, D. K. W., Yiu, K. K. L., Chu, S. H. T., Chan, H. Y., Woo, J., Chan, F. K. L., & Chan, H. L. Y. (2012). Hepatitis B virus infection and fatty liver in the general population. Journal of Hepatology, 56(3), 533–540. https://doi.org/10.1016/j.jhep.2011.09.013
Tan, X., Xiang, Y., Shi, J., Chen, L., & Yu, D. (2024). Targeting NTCP for liver disease treatment: A promising strategy. Journal of Pharmaceutical Analysis, 100979.
Jain, D. M. H., Kapur, K. S., & Sikarwar, S. S. (2022). A CLINICAL STUDY OF CIRRHOSIS WITH SPECIAL REFERENCE TO THYROID FUNCTION”. European Journal of Molecular & Clinical Medicine, 9(7), 151–161.
Tan, A., Koh, S., & Bertoletti, A. (2015). Immune response in hepatitis B virus infection. Cold Spring Harbor Perspectives in Medicine, 5(8), a021428.
Dar, M., Gupta, S., & Gowhar, O. (2019). Estimation of hematological parameters in patients with Hepatitis B and C. 6(11), 76–80.
Zhou, R., Song, Y., Xu, C., Zhang, Y., Wu, X., Zhang, L., Luo, X., Zhao, H., Liu, M., & Xu, J. (2024). Altered counts and mitochondrial mass of peripheral blood leucocytes in patients with chronic hepatitis B virus infection. Journal of Cellular and Molecular Medicine, 28(12), e18440.
Jalil, A. T., Dilfy, S. H., Karevskiy, A., & Mubark, N. N. (2020). Viral hepatitis in Dhi-Qar province: demographics and hematological characteristics of patients. International Journal of Pharmaceutical Research, 12(1), 2081–2087. https://doi.org/10.31838/ijpr/2020.12.01.326
Raadsen, M., Du Toit, J., Langerak, T., van Bussel, B., van Gorp, E., & Goeijenbier, M. (2021). Thrombocytopenia in virus infections. Journal of Clinical Medicine, 10(4), 877.
Ahsan, A., Tariq, M. D., Zafar, M., Hamza, H. M., Kaleem, F., Malik, M. M., & Awan, A. A. (2024). Analysis of Hematological Profiles in Hepatitis B Patients; Understanding the Interplay Between Viral Infections and Blood Parameters. Journal of Nursing & Healthcare, 9(2), 1–6.
Shah, D., Talwar, D., Kumar, S., & Acharya, S. (2023). Platelet Indices: Is it a Reliable Biomarker in Viral Infections? Journal of Datta Meghe Institute of Medical Sciences University, 18(2), 322–326.
Barišić, J. (2024). Prikupljanje plazme i trombocita postupkom afereze u Zavodu za transfuzijsku medicinu KBC Split (2021.-2022.). University of Split. University Department of Health Studies.
Hsieh, Y.-P., Chang, C.-C., Kor, C.-T., Yang, Y., Wen, Y.-K., & Chiu, P.-F. (2017). Mean corpuscular volume and mortality in patients with CKD. Clinical Journal of the American Society of Nephrology, 12(2), 237–244.
Mir, S. A., & Alshehri, B. (2021). Seroprevalence of hepatitis b and c viral infections in the premarital adult population of al majmaah, saudi arabia. Malawi Medical Journal, 33(3), 221–225. https://doi.org/10.4314/mmj.v33i3.10
Published
How to Cite
Issue
Section
License
Copyright (c) 2025 Journal of Contemporary Medical Sciences
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
